Case number 1:22-cv-00431
NOVARTIS PHARMACEUTICALS CORPORATION et al v. ACCORD HEALTHCARE INC. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 8, 2022 | 1 | Complaint* (1) |
| Jun 23, 2022 | 7 | Notice of Voluntary Dismissal (case) (2) Docket Text: NOTICE of Voluntary Dismissal of case by Plaintiffs DANA-FARBER CANCER INSTITUTE, INC., NOVARTIS PHARMACEUTICALS CORPORATION (CHAMBERLIN, ANDREW) |
| Jun 8, 2022 | N/A | Case Assigned (0) Docket Text: Case ASSIGNED to JUDGE WILLIAM L. OSTEEN, JR and MAG/JUDGE JOI ELIZABETH PEAKE. (Carter, Alexus) |
| Jun 8, 2022 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Mediation pursuant to Local Rule 83.9b of the Rules of Practice and Procedure of this Court. Please go to our website under Attorney Information for a list of mediators which must be served on all parties. (Carter, Alexus) |
| Jun 8, 2022 | 5 | Main Document (2) Docket Text: Summons Issued as to All Defendants. (Attachments: # (1) Summons - INTAS PHARMACEUTICALS LTD.) (Carter, Alexus) |
| Jun 8, 2022 | 5 | Summons - INTAS PHARMACEUTICALS LTD. (2) |
| Jun 8, 2022 | 6 | Main Document (1) Docket Text: Notice of Right to Consent. Counsel shall serve the attached form on all parties. (Attachments: # (1) Consent Form) (Carter, Alexus) |
| Jun 8, 2022 | 6 | Consent Form (1) |
| Jun 7, 2022 | 1 | Main Document (11) Docket Text: COMPLAINT against All Defendants (Filing fee $ 402 receipt number ANCMDC-3314564), filed by NOVARTIS PHARMACEUTICALS CORPORATION, DANA-FARBER CANCER INSTITUTE, INC. (Attachments: # (1) Exhibit A - US797303) (CHAMBERLIN, ANDREW) Modified on 6/8/2022 to remove duplicate text in attachment title. (Sheets, Jamie) |
| Jun 7, 2022 | 1 | Exhibit A - US797303 (25) |
| Jun 7, 2022 | 2 | Corporate Disclosure Statement (2) Docket Text: Corporate Disclosure Statement by Plaintiffs NOVARTIS PHARMACEUTICALS CORPORATION, NOVARTIS AG identifying Corporate Parent NOVARTIS AG for NOVARTIS PHARMACEUTICALS CORPORATION.. (CHAMBERLIN, ANDREW) |
| Jun 7, 2022 | 3 | Corporate Disclosure Statement (2) Docket Text: Corporate Disclosure Statement by Plaintiff DANA-FARBER CANCER INSTITUTE, INC. (CHAMBERLIN, ANDREW) |
